Invitrogen Becomes First Shop to Sign On to Crucell’s PER.C6 Vendor Network | GenomeWeb
NEW YORK (GenomeWeb News) - Dutch biotech Crucell and DSM Biologics today said that Invitrogen will become the first company to enter the partnership's licensing business, Vendor Network, for monoclonal antibodies and recombinant proteins.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.